Accessible Search Form           Advanced Search

  • PRINT PAGE  |  PRINT ENTIRE TOPIC  |  SHARE

Clinical Trials

The National Heart, Lung, and Blood Institute (NHLBI) is strongly committed to supporting research aimed at preventing and treating heart, lung, and blood diseases and conditions and sleep disorders.

Researchers have learned a lot about heart diseases and conditions over the years. This has led to advances in medical knowledge and care. However, many questions remain about heart diseases and conditions, including cardiomyopathy.

The NHLBI continues to support research aimed at learning more about heart diseases and conditions. For example, NHLBI-supported research on cardiomyopathy includes studies that explore:

  • Whether certain medicines improve heart function in people who have cardiomyopathy
  • How certain therapies can help treat cardiomyopathy and improve quality of life for people who have the disease

Much of this research depends on the willingness of volunteers to take part in clinical trials. Clinical trials test new ways to prevent, diagnose, or treat various diseases and conditions.

For example, new treatments for a disease or condition (such as medicines, medical devices, surgeries, or procedures) are tested in volunteers who have the illness. Testing shows whether a treatment is safe and effective in humans before it is made available for widespread use.

By taking part in a clinical trial, you can gain access to new treatments before they're widely available. You also will have the support of a team of health care providers, who will likely monitor your health closely. Even if you don't directly benefit from the results of a clinical trial, the information gathered can help others and add to scientific knowledge.

If you volunteer for a clinical trial, the research will be explained to you in detail. You'll learn about treatments and tests you may receive, and the benefits and risks they may pose. You'll also be given a chance to ask questions about the research. This process is called informed consent.

If you agree to take part in the trial, you'll be asked to sign an informed consent form. This form is not a contract. You have the right to withdraw from a study at any time, for any reason. Also, you have the right to learn about new risks or findings that emerge during the trial.

For more information about clinical trials related to cardiomyopathy, talk with your doctor. You also can visit the following Web sites to learn more about clinical research and to search for clinical trials:

For more information about clinical trials for children, visit the NHLBI's Children and Clinical Studies Web page.

Rate This Content:

  
previous topic next topic
Cardiomyopathy Clinical Trials

Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Cardiomyopathy, visit www.clinicaltrials.gov.


Cardiomyopathy in the News

September 3, 2013
Risk factors identified at diagnosis help predict outcomes for children with rare heart condition
A long-term study of children with a complex heart condition called hypertrophic cardiomyopathy (HCM) found that risk factors identified at diagnosis help to predict outcomes for children with this rare condition.

View all Cardiomyopathy Press Releases


 
January 01, 2011 Last Updated Icon

The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.